• Home

 

 

  • About Us
    • Overview
    • Welcome
    • Vision & Values
    • Community Relations
    • History
    • Officers
    • Board of Directors
    • Customer Relationships
    • Business Development
  • Clinical Markets
    • Overview
    • Cardiovascular
    • Ophthalmology
    • Pharmaceuticals
    • In Vitro Diagnostics
    • Other Clinical Markets
  • Technologies
    • Overview
    • Drug Delivery
    • Surface Modification
  • Investors
    • Investor Overview
    • Officers
    • Directors
    • Stock Performance
    • Financial Highlights
    • News Releases
    • Analyst Coverage
    • Annual Reports
    • Corporate Governance
    • SEC Filings
    • Conference Calls
    • IR Events
    • Presentations
    • Investor Inquiries
  • News & Events
    • Events Calendar
    • News Releases
  • Careers
    • Overview
    • Open Positions
    • Network with SurModics
    • Company Culture
    • Benefits
    • Business Overview
  • Home
  • Contact Us
Advancing diagnostic and therapeutic applications.
  • Cardiovascular
  • Ophthalmology
  • Pharmaceuticals
  • In Vitro Diagnostics
  • Other Clinical Markets
Enabling the performance and enhancing the functionality of medical devices, drugs, and diagnostics.
  • Drug Delivery
  • Surface Modification


Recent News

SurModics and EGEN Announce Collaboration

SurModics Showcases Drug Delivery Technology at The 37th Annual Meeting and Exposition of the Controlled Release Society

SurModics Signs License Agreement with Clinuvel Pharmaceuticals

SurModics Receives ISO Certification at SurModics Pharmaceuticals Facilities

SurModics Showcases New Assay Application at Luminex xMAP Symposium

SurModics Opens World-class cGMP Facility for Manufacturing and Development in Birmingham, Alabama

New Manfacturing Facility Video

 

 

Privacy Policy | Terms of Use | © 2009 SurModics, Inc. All Rights Reserved